NEWS
Pacific Smiles 11pc holder backs $300m Genesis bid
SYDNEY: It’s Groundhog Day at takeover target Pacific Smiles as shareholders line up behind its… read more
Drug developer rattles tin for another cash dollop
MELBOURNE: Neurological diseases drug development company Actinogen Medical, capitalised at $95 million on the ASX,… read more
Multigenerational housing makes comeback as market conditions improve
MELBOURNE: Key multigenerational housing markets are now making a comeback as market conditions begin to… read more
